MedTrace Logo

Multi-omic Approach to Cancer Diagnosis: the Italian Network of Excellence for Advanced Diagnosis (INNOVA)

NCT06884878 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 103

Last updated 2025-03-24

No results posted yet for this study

Summary

The INNOVA project aims to create an advanced multidisciplinary diagnostic platform to support the Italian healthcare system and translational research. In this context, WP7, coordinated by the Pascale Institute and the focus of this study protocol, is responsible for developing a national platform for the multi-omic profiling of cancer patients eligible for precision medicine treatments, with the goal of supporting clinical decision-making.

Conditions

  • Neoplasms

Interventions

OTHER

Multi-omic approach to cancer diagnosis.

To assess the impact of intratumoral heterogeneity on the effectiveness of targeted therapies and immunotherapy.

Sponsors & Collaborators

  • National Cancer Institute, Naples

    lead OTHER

Principal Investigators

  • Antonella De Luca · IRCCS I.N.T. "G. Pascale"

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-08
Primary Completion
2026-11-30
Completion
2026-11-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06884878 on ClinicalTrials.gov